Cytotoxic Spliceostatins fromBurkholderiasp. and Their Semisynthetic Analogues-Reference-Cited by-同舟云学术

Cytotoxic Spliceostatins fromBurkholderiasp. and Their Semisynthetic Analogues

Published:2014-08-06 Issue:8 Volume:77 Page:1864-1870
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

He Haiyin¹,Ratnayake Anokha S.¹,Janso Jeffrey E.¹,He Min²,Yang Hui Y.³,Loganzo Frank⁴,Shor Boris⁴,O’Donnell Christopher J.¹,Koehn Frank E.¹

Affiliation:

1. Natural Products Laboratory, Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States

2. Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, Maryland 20892, United States

3. Novartis Institutes for BioMedical, Research, Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States

4. Pfizer Oncology, 401 N. Middletown Road, Pearl River, New York 10965, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/np500342m

Reference30 articles.

1. The spliceosome as target for anticancer treatment

2. Targeting the spliceosome

3. The emerging role of splicing factors in cancer